ARCHIVES

RELATED POSTS

Related Posts

CBD Insider’s Update: Week of March 16, 2020

A lot is going on here in the US and internationally – and the CBD Association has got you covered! Here is what happened just in the past few weeks: USDA Secretary calls interim hemp rules a ‘draft.’ Hemp farmers and stakeholders welcomed a late February announcement when the USDA (for now) lifted enforcement action requiring that hemp be tested in U.S. Drug Enforcement...

read more

Key Issues Everyone Must Consider When Reading FDA’s CBD Report To Congress

Executive Summary // On March 5, FDA issued a 15-page report to Congress concerning CBD. Below, the CBD Association explores five issues raised by that report and invites feedback. Those issues are: 1. Can FDA and the Administration define an acceptable regulatory pathway for use of CBD in non-drug products that would not impede its further development as a pharmaceutical? As the FDA considers...

read more

Key Issues Everyone Must Consider When Reading FDA’s CBD Report To Congress

Executive Summary:  On March 5, FDA issued a 15-page report to Congress concerning CBD. Below, the CBD Association explores five issues raised by that report and invites feedback. Those issues are: 1. Can FDA and the Administration define an acceptable regulatory pathway for use of CBD in non-drug products that would not impede its further development as a pharmaceutical? As the FDA considers...

read more

Federal and State Insider’s Update: Week of March 9, 2020

At the CBD Association, we hear from two broad classes of stakeholders interested in legislative developments involving cannabinoids, especially CBD. The first are businesses which today have ‘skin in the game’. These include growers, processors, contract manufacturers, brand owners, retailers, and allied industries. The second group includes (a) companies which may have quietly commissioned...

read more

Federal and State Insider’s Update: Week of March 9, 2020

  At the CBD Association, we hear from two broad classes of stakeholders interested in legislative developments involving cannabinoids, especially CBD. The first are businesses which today have ‘skin in the game’. These include growers, processors, contract manufacturers, brand owners, retailers, and allied industries. The second group includes (a) companies which may have quietly...

read more

Comments To The USDA Concerning The Interim Final Rule for The U.S. Domestic Hemp Program

On behalf of the CBD Association and its member companies, we are submitting comments concerning the Interim Final Rule for the U.S. Domestic Hemp Program (the “IFR”).1 The CBD Association (CBDA) is the only 501(c)(6) non-profit trade association established in Washington, D.C. that exclusively and holistically promotes CBD and cannabis-derived products worldwide. CBDA engages policymakers at...

read more

OUR TEAM

MORE ABOUT US  +

ADVOCACY

MORE  〉

EDUCATION

FIND OUT MORE  +

BECOME A MEMBER

JOIN TODAY +

UPCOMING EVENTS

FIND EVENTS +

VERIFICATION

FIND OUT MORE  +

BUSINESS SERVICES

MORE INFO +

COMMUNCATIONS

MORE ABOUT US  〉